pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    ganciclovir sodium
    Ganciclovir Sodium
    Cytomegalovirus (CMV) Retinitis Slate Run Pharmaceuticals LLC
  • Phase 2
    genistein
    genistein
    Pulmonary Fibrosis Humanetics Corp
  • Marketed
    gentamicin sulfate
    Gentamicin Sulfate
    Bacterial Blepharoconjunctivitis Fera Pharmaceuticals LLC
  • Marketed
← prev
page 18 of 24
next →
Pain89
Neurology1
griseofulvin
Griseofulvin
Tinea Barbae
Teva Pharmaceuticals USA Inc
  • Marketed
    haemophilus influenzae [serotype B] vaccine
    ActHIB
    Diphtheria Sanofi Pasteur Inc
  • Phase 2
    hemorrhagic fever vaccine
    Hemorrhagic Fever US Army Medical Research & Materiel Command
  • Marketed
    hepatitis A vaccine
    Havrix
    Hepatitis A GlaxoSmithKline LLC
  • Marketed
    hepatitis B immune globulin (human)
    Hepagam B (hepatitis B immune globulin (human))
    Hepatitis B Aptevo BioTherapeutics LLC
  • Marketed
    hepatitis B vaccine
    Heplisav-B
    Hepatitis B Dynavax Technologies Corp
  • Preclinical
    herpes simplex virus 1 [strain (VC2)] vaccine
    Simplexvirus (HSV) Infections Rational Vaccines Inc
  • Preclinical
    herpes simplex virus 2 vaccine
    Genital Herpes BlueWillow Biologics Inc
  • Marketed
    human papillomavirus (virus like particle, 9-valent) vaccine
    Gardasil 9
    Cervical Intraepithelial Neoplasia (CIN)$MRK Merck & Co., Inc.
  • Marketed
    hydroxychloroquine
    Hydroxychloroquine Sulfate (hydroxychloroquine [INN])
    Malaria Creekwood Pharmaceutical Inc
  • Preclinical
    iXB-322
    Coronavirus Disease 2019 (COVID-19) iX Biopharma Ltd
  • Marketed
    ibalizumab
    Trogarzo (ibalizumab-uiyk)
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Theratechnologies Inc
  • Phase 2
    ibezapolstat
    ibezapolstat
    Clostridioides difficile Infections (Clostridium difficil…$ACXP Acurx Pharmaceuticals, Inc.
  • Phase 3
    ibramvibart
    ibramvibart [INN]
    Coronavirus Disease 2019 (COVID-19)$IVVD Invivyd, Inc.
  • Phase 3
    ibudilast
    ibudilast [INN]
    Amyotrophic Lateral Sclerosis$MNOV MEDICINOVA INC
  • Phase 3
    ibuzatrelvir
    ibuzatrelvir
    Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
  • Phase 2
    imdusiran sodium
    imdusiran sodium
    Hepatitis B$ABUS Arbutus Biopharma Corp
  • Phase 3
    influenza (quadrivalent) vaccine
    Influenzavirus A Infections$PFE PFIZER INC
  • Phase 3
    influenza (trivalent) vaccine
    Seasonal Influenza$NVAX NOVAVAX INC
  • Phase 2
    influenza [Strain H5] vaccine
    Pandemic Influenza$SNY Sanofi
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent) vaccine
    Flublok Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections Sanofi Pasteur Inc
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine
    Flulaval Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections GlaxoSmithKline Consumer Healthcare LP
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B] (split virion) vaccine
    Fluzone
    Influenza A Virus, H1N1 Subtype Infections Sanofi Pasteur Inc
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
    Flucelvax
    Influenza A Virus, H1N1 Subtype Infections Seqirus Ltd
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine
    Afluria
    Influenza A Virus, H1N1 Subtype Infections Seqirus Ltd
  • Preclinical
    influenza [strains A/H1N1] vaccine
    Influenza A Virus, H1N1 Subtype Infections CEL-SCI Corp
  • Marketed
    influenza [types A and B] (quadrivalent) vaccine
    Flucelvax Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections Seqirus Ltd